Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
27.55
-0.30 (-1.08%)
At close: May 9, 2025, 4:00 PM
27.55
0.00 (0.00%)
After-hours: May 9, 2025, 7:59 PM EDT

Viking Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-128.24-109.96-85.9-68.87-54.99-39.5
Upgrade
Depreciation & Amortization
0.380.350.290.290.30.28
Upgrade
Other Amortization
0.090.090.090.060.020.11
Upgrade
Loss (Gain) From Sale of Investments
-17.69-17.38-8.21.223.913.77
Upgrade
Stock-Based Compensation
33.0829.7116.758.676.15.82
Upgrade
Other Operating Activities
0.040.040.040.040.010.03
Upgrade
Change in Accounts Payable
2.482.3-1.027.09-2.541.56
Upgrade
Change in Other Net Operating Assets
-24.137.064.573.1-0.386.16
Upgrade
Operating Cash Flow
-133.99-87.79-73.38-48.4-47.59-21.78
Upgrade
Investment in Securities
-30.33-553.37-179.0954.7537.9641.57
Upgrade
Investing Cash Flow
-30.33-553.37-179.0954.7537.9641.57
Upgrade
Issuance of Common Stock
6.78654.57278.512.517.631.27
Upgrade
Repurchase of Common Stock
--42.1-7.12-8.33-0.71-0.3
Upgrade
Other Financing Activities
----0.02-0.05-0.03
Upgrade
Financing Cash Flow
6.78612.46271.384.166.880.95
Upgrade
Foreign Exchange Rate Adjustments
-0.1-0.15-0.03-0.26--
Upgrade
Net Cash Flow
-157.64-28.8418.8810.26-2.7520.74
Upgrade
Levered Free Cash Flow
-98.38-55.58-42.36-25.22-32.16-15.06
Upgrade
Unlevered Free Cash Flow
-98.41-55.61-42.4-25.24-32.16-15.1
Upgrade
Change in Net Working Capital
24.18-8.66-3.58-9.763.76-5.47
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q